Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motor neuron disease: whole-brain magnetic resonance spectroscopy measures hold promise as new biomarkers for disability in ALS.

Nature reviews. Neurology·2013
Same author

APRIL suppresses CIA in mice.

Nature reviews. Rheumatology·2012
Same author

Chemotherapy. Intensified therapy for Ewing sarcoma.

Nature reviews. Clinical oncology·2012
Same author

Diabetes: unhealthy lifestyle and obesity explain half of socioeconomic differences in T2DM.

Nature reviews. Endocrinology·2012
Same author

Thyroid gland: vandetanib for thyroid cancer.

Nature reviews. Endocrinology·2012
Same author

Pituitary function: Mitotane--safe and effective for Cushing disease?

Nature reviews. Endocrinology·2012

Related Experiment Video

Updated: Jun 1, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

ROR blockers inhibit T(H)17 cells

Iley Ozerlat

    Nature Reviews. Neurology
    |June 10, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
    12:08

    Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

    Published on: November 15, 2024

    In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse
    07:46

    In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse

    Published on: October 25, 2024

    Related Experiment Videos

    Last Updated: Jun 1, 2026

    Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
    12:59

    Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

    Published on: September 26, 2013

    Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
    12:08

    Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

    Published on: November 15, 2024

    In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse
    07:46

    In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse

    Published on: October 25, 2024